Results 261 to 270 of about 1,067,890 (357)
Paeonol Inhibits Cell Growth by Inducing Ferroptosis in Human Glioma Cells. [PDF]
Li X +8 more
europepmc +1 more source
Scientometric Mapping of Pharmaceutical Science Research in India during 2011-2020 [PDF]
Sowmya C Sowmya +2 more
openalex +1 more source
Porous silicon nanoparticles (PSiNPs) reprogram macrophage endocytosis of manganese@albumin‐based TLR4 nanoagonists, driving TRIF‐biased TLR4 signaling, eliciting robust proinflammatory responses, and potentiating macrophage‐mediated immunotherapeutic effects against NSCLC.
Xiaomei Zhang +9 more
wiley +1 more source
Development of machine learning predictive models for estimating pharmaceutical solubility in supercritical CO<sub>2</sub>: case study on lornoxicam solubility. [PDF]
Chao L +6 more
europepmc +1 more source
The study presents biodegradable and recyclable mixed‐matrix membranes (MMMs), hydrogels, and cryogels using luminescent nanoscale metal‐organic frameworks (nMOFs) and biopolymers. These bio‐nMOF‐MMMs combine europium‐based nMOFs as probes for the status of the materials with the biopolymers agar and gelatine and present alternatives to conventional ...
Moritz Maxeiner +4 more
wiley +1 more source
Quality Indicators for Drug Dispensing in Community Pharmacies: A Scoping Review Protocol. [PDF]
Caxico-Vieira LJS +6 more
europepmc +1 more source
Research on Gilead Sciences’ Market Monopolization Strategies and Their Economic Impact on the Global Pharmaceutical Market [PDF]
Connie Zheng
openalex +1 more source
Selective Benzene Capture by Metal‐Organic Frameworks
Metal‐organic frameworks (MOFs) hold significant potential for capturing benzene from air emissions and hydrocarbon mixtures in liquid phases. This capability stems from their precisely engineered structures, versatile chemistries, and diverse binding interactions.
Zongsu Han +4 more
wiley +1 more source
Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study. [PDF]
Inokuchi A +14 more
europepmc +1 more source

